DERM
Journey Medical Corp

3,070
Loading...
Loading...
News
all
press releases
New Strong Sell Stocks for September 4th
DERM, HOPE and NXRT have been added to the Zacks Rank #5 (Strong Sell) List on September 4, 2025.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates
Journey Medical (DERM) delivered earnings and revenue surprises of -128.57% and +1.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·26d ago
News Placeholder
3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.
Zacks·28d ago
News Placeholder
Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Journey Medical (DERM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates
chainwire·4mo ago
News Placeholder
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates
chainwire·4mo ago
News Placeholder
What's Going On With Journey Medical Stock Today?
Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea. read more...
Benzinga·10mo ago
News Placeholder
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Record consolidated net revenue of $84.5 million for full-year 2023 Fortress may receive up to four regulatory decisions on NDAs and BLAs in the next 18 months FDA accepted New Drug Application...
Globe Newswire·1y ago
News Placeholder
Journey Medical Co. (NASDAQ:DERM) Director Lindsay A. Md Rosenwald Acquires 10,000 Shares of Stock
Journey Medical Co. (NASDAQ:DERM Get Free Report) Director Lindsay A. Md Rosenwald acquired 10,000 shares of Journey Medical stock in a transaction that occurred on Monday, March 25th. The...
Ticker Report·1y ago

Latest DERM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.